AMPH Amphastar Pharmaceuticals Inc

Amphastar Pharmaceuticals Inc is a specialty pharmaceutical company engaged in developing, manufacturing, marketing and selling generic and proprietary injectable & inhalation products. Its products are used in hospitals or urgent care clinical settings.

$34.79  +0.64 (1.87%)
As of 06/30/2022 15:59:58 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  USA
IPO date:  06/25/2014
Outstanding shares:  48,829,793
Average volume:  794,877
Market cap:   $1,623,590,617
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BNFWZS4

---

Valuation   (See tab for details)

---

PE ratio:   20.50
PB ratio:   3.47
PS ratio:   3.57
Return on equity:   16.96%
Net income %:   17.87%